Arcus Capital Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-3,990
Closed -$300K – 151
2025
Q3
$300K Hold
3,990
– – 0.13% 93
2025
Q2
$296K Hold
3,990
– – 0.13% 98
2025
Q1
$322K Sell
3,990
-123
-3% -$10.6K 0.13% 88
2024
Q4
$374K Buy
4,113
+119
+3% +$10.1K 0.12% 81
2024
Q3
$375K Sell
3,994
-119
-3% -$9.99K 0.14% 77
2024
Q2
$320K Hold
4,113
– – 0.12% 84
2024
Q1
$374K Hold
4,113
– – 0.12% 81
2023
Q4
$318K Sell
4,113
-1,041
-20% -$72.9K 0.11% 77
2023
Q3
$351K Sell
5,154
-3
-0.1% -$218 0.11% 81
2023
Q2
$419K Sell
5,157
-8
-0.2% -$638 0.13% 72
2023
Q1
$424K Buy
+5,165
New +$369K 0.14% 68

Other funds holding GEHC

Arcus Capital Partners's GEHC Position: Q4 2025 in Review

Arcus Capital Partners sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 3,990 shares — an estimated $300K sold.

Arcus Capital Partners first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $424K in Q1 2023. 1,338 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • Arcus Capital Partners reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
  • Arcus Capital Partners sold 3,990 GE HealthCare shares in Q4 2025, an estimated $300K.
  • Arcus Capital Partners first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
  • Arcus Capital Partners's GE HealthCare position peaked at $424K in Q1 2023.
  • 1,338 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Arcus Capital Partners's 13F filing for Q4 2025, filed 6 May 2026.